StockTipsArenaBeta

BUY Medplus Health Services Limited — Nomura India Research

BUYMedplus Health Services Limited
Medplus Health Services share price target & all analyst calls

byNomura India ResearchHorizon: NA (inferred 1 year)30 Oct 2026via ET Now (Live)

Entry₹590Inferred
Target₹915
Total upside +55.08%
Stop lossNot given
CMP₹579.95h ago
Active-1.71%+57.79%upside left 12 mo left
Follow Nomura India Research for new calls(100% target hit, 27 closed calls)Get alertsWatch MEDPLUS for new buy/sell callsGet alertsSee 2 other Long-term calls on MEDPLUSSee 410 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:23 pm IST
3 supporting2 neutral1 opposing
Supports the BUY call (3)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·22 May · 5mo ago

Neutral / worth noting (2)

MedPlus Q2 Results: Net profit flat as revenue surges 21%; store-level ROCE at 72%

NewsCnbc-Tv18·27 Oct · 3d ago

(opens in new tab)
Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·30 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Medplus Health Services

All analyst calls on Medplus Health Services

More from Nomura India Research

Every call and its outcome